American Society of Nuclear Cardiology 31st Annual Scientific Session & Exhibition 2026

ASNC2026 focuses on how nuclear cardiology informs cardiovascular diagnosis and management. The program examines cardiac PET and SPECT, quantitative myocardial blood flow, emerging tracers and artificial intelligence, alongside imaging for amyloidosis, sarcoidosis, infection and ischemic heart disease. Laboratory quality, technical standards, reimbursement and team-based care connect the imaging science with day-to-day practice.

The original meeting ran September 16–19, 2026 in Las Vegas, with a virtual program on September 26. The session list below preserves the published topics for clinicians, imaging specialists and technologists. It describes the conference program rather than a verified file manifest; live workshops, software access and provider registration are separate from this purchase.

Scientific Program Leadership

Paul Cremer, MD, MS

ASNC2026 Program Chair

Brett Sperry, MD, FASNC

Program Vice Chair

Roxana Campisi, MD, MASNC

International Vice Chair

The program committee includes experts in cardiac PET, SPECT, amyloidosis, molecular imaging, advanced tracers, myocardial ischemia, cardiovascular inflammation, and nuclear cardiology practice.

Learning Objectives

The scientific program supports the following educational goals:

1. Evaluate emerging PET and SPECT radiotracers for myocardial perfusion, cardiac amyloidosis, inflammation, and myocardial fibrosis.
2. Understand how artificial intelligence may improve cardiovascular image reconstruction, interpretation, workflow, and laboratory efficiency.
3. Apply multimodality imaging principles when evaluating cardiac amyloidosis, nonischemic cardiomyopathies, and heart failure.
4. Differentiate cardiac infection from sterile inflammation using FDG-PET and complementary imaging techniques.
5. Interpret quantitative myocardial blood flow and myocardial flow reserve measurements within clinical cardiovascular assessment.
6. Review contemporary imaging approaches to coronary atherosclerosis and myocardial ischemia.
7. Identify technical considerations affecting image quality, including attenuation correction, acquisition protocols, and artifacts.
8. Explore emerging nuclear cardiology technologies and radiopharmaceutical developments.
9. Apply evidence-based imaging principles to risk stratification and treatment planning.
10. Understand laboratory management, reimbursement, regulatory compliance, and quality improvement.
11. Evaluate the role of cardiac PET and SPECT in the cardiovascular-kidney-metabolic continuum.
12. Improve multidisciplinary collaboration among cardiovascular imaging professionals.

Topics

• Mario Verani Memorial Lecture, Presidential Addresses, and ASNC Award Presentations

• ASNC2026 Keynote Lecture: On Calling – Preserving the Sanctity of Medicine in Changing Times

• Next Generation Technology in Nuclear Cardiology

• Myocardial Blood Flow and Flow Reserve – From Concept to Console

• CME Breakfast Symposium: Early Diagnosis of ATTR CM – An Evolving Story

• ASNC Awards: Imaging the Cardiovascular-Kidney-Metabolic (CKM) Continuum – The Expanding Role of Nuclear Cardiology

• ASNC Awards and Plenary: Nuclear Cardiology in Nonischemic Cardiomyopathies

• The Pipeline of Cardiac PET Tracers

• Cardiac FDG PET Imaging: Not All That Glitters Is Inflammation

• Challenges in Reading FDG-PET in Cardiovascular Infections

• Diagnosis and Treatment of Cardiac Sarcoidosis – Current and Future of Complex Disease

• When to Revascularize: Plaque, Ischemia, Flow and Beyond

• Myocardial Viability: Evidence, Controversies and an Imaging Showdown

• Back to Basics: Imaging and Non-Imaging Stress Testing

• Translating AI Into Clinical Practice

• The Evolving Role of the Advanced Imaging Reader

• The Year in Evidence: Practice-Changing Science from JNC

• Late-Breaking Clinical Science

• Barry L. Zaret Young Investigator Awards Competition

• Amyloidosis Center of Excellence and Multispecialty Involvement

• Team-Based Care and the Nuclear Cardiology Patient Journey

• Billing, Compliance, and the Future of Nuclear Cardiology Reimbursement

• Charting Your Course: Jobs, Research, and Leadership in Nuclear Cardiology

• Lunch and Learn (Sponsored by Bracco Diagnostics): A New Century for Cardiac PET – Blood Flow Quantification as a Roadmap to Treatment

• Getting It Right at the Table: Technologist Strategies for High-Quality Cardiac SPECT & PET

• Virtual Track – CT in Nuclear Cardiology: Attenuation Correction, Mapping and Calcium Scoring (V101)

• Virtual Track – Beyond Perfusion: PET/SPECT/CT for Infection, Sarcoid, and Amyloid Imaging (V102)

• Virtual Track – Optimizing Cardiac SPECT MPI: From Stress Performance to Findings That Change Management (V103)

• Scientific Abstracts & Case Presentations:

  • Rapid-Fire Cases: Amyloidosis and Heart Failure

  • Oral Abstracts: Amyloidosis and Heart Failure

  • Oral Abstracts: Myocardial Ischemia and Atherosclerosis

  • Oral Abstracts: Technology, Tracers, Instrumentation, Software

  • Rapid Fire Cases: Myocardial Ischemia and Atherosclerosis

  • Lightning Round Cases: Infection and Inflammation (includes Sarcoidosis)

  • Lightning Round Cases: Myocardial Ischemia and Atherosclerosis

  • Rapid Fire Cases: Infection and Inflammation (includes Sarcoidosis)

  • Rapid-Fire Cases: Infection and Inflammation (includes Sarcoidosis) and Technology, Tracers, Instrumentation, Software

  • Oral Abstracts: Infection and Inflammation (includes Sarcoidosis)